Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120,284,725
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
17,606,263
-
Shares change
-
+3,899,142
-
Total reported value, excl. options
-
$198,949,802
-
Value change
-
+$44,387,028
-
Put/Call ratio
-
51%
-
Number of buys
-
34
-
Number of sells
-
-32
-
Price
-
$11.30
Significant Holders of IMMUNIC, INC. - Common Stock (IMUX) as of Q1 2022
96 filings reported holding IMUX - IMMUNIC, INC. - Common Stock as of Q1 2022.
IMMUNIC, INC. - Common Stock (IMUX) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17,606,263 shares
of 120,284,725 outstanding shares and own 15% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (2,705,513 shares), Omega Fund Management, LLC (1,788,160 shares), BlackRock Inc. (1,314,484 shares), COWEN AND COMPANY, LLC (1,257,146 shares), Parkman Healthcare Partners LLC (1,089,251 shares), VANGUARD GROUP INC (956,697 shares), COMMODORE CAPITAL LP (893,013 shares), Point72 Asset Management, L.P. (725,000 shares), Artal Group S.A. (700,000 shares), and PURA VIDA INVESTMENTS, LLC (683,287 shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.